MyCareTeam logo
MyCareTeam, Inc. has received clearance from the United States Food & Drug Administration (FDA) for its flagship diabetes management software product, MCT-Diabetes. MCT-Diabetes enables people with diabetes to securely upload blood glucose (sugar) readings from their glucose meter and communicate electronically with their caregivers.
MyCareTeam pursued the rigorous clearance process in order to provide its consumer base with an enhanced diabetes monitoring product that is cleared by the FDA. MCT-Diabetes is one of the first software-only diabetes management companies to receive FDA clearance in the United States.
“We are extremely pleased to be able to offer our customers an FDA cleared version of MCT-Diabetes”
MCT-Diabetes guides people with diabetes to make the required behavioral and medication changes supported by frequent feedback and input from caregivers.
MCT-Diabetes offers a unique and personalized way to share and monitor blood glucose levels, keep track of medications, log blood pressure, track lab results, and build and maintain an exercise log. MCT-Diabetes also allows people with diabetes to invite individuals into their health-management support circle, and provides an interactive method for receiving feedback in the form of charts and graphs.
On October 4th, 2007, Richard Kahn, PhD, Chief Scientific and Medical Officer, American Diabetes Association, said: “We believe that this tool may further engage people in the learning process about managing their diabetes. Such a web-based platform may improve the dialogue between the patient and their health care team.”
Because of MCT-Diabetes’
Photo:
http://www.prlog.org/
